[PDF][PDF] Is the organ care system (OCS) still the first choice with emerging new strategies for donation after circulatory death (DCD) in heart transplant?

M Alomari, P Garg, JH Yazji, IJ Wadiwala… - Cureus, 2022 - cureus.com
The scarcity of donor hearts continues to be a challenge in transplants for advanced heart
failure patients. With an increasing number of patients on the waiting list for a heart …

Vericiguat: The Fifth Harmony of heart failure with reduced ejection fraction

L Falco, B Brescia, D Catapano, ML Martucci… - Journal of …, 2023 - mdpi.com
Heart failure with reduced ejection fraction is a chronic and progressive syndrome that
continues to be a substantial financial burden for health systems in Western countries …

Role of macrophages in regression of myocardial fibrosis following alleviation of left ventricular pressure overload

LS Neff, RM Biggs, Y Zhang… - American Journal …, 2024 - journals.physiology.org
Sustained hemodynamic pressure overload (PO) produced by murine transverse aortic
constriction (TAC) causes myocardial fibrosis; removal of TAC (unTAC) returns left ventricle …

[HTML][HTML] Economic Evaluations of Digital Health Interventions for Patients With Heart Failure: Systematic Review

N Zakiyah, D Marulin, M Alfaqeeh… - Journal of Medical …, 2024 - jmir.org
Background Digital health interventions (DHIs) have shown promising results in enhancing
the management of heart failure (HF). Although health care interventions are increasingly …

[HTML][HTML] Is it time for class I recommendation for sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction?: An …

S Treewaree, N Kulthamrongsri… - Frontiers in …, 2023 - frontiersin.org
Background In heart failure with reduced ejection fraction (HFrEF), sodium-glucose
cotransporter-2 (SGLT2) inhibitors were demonstrated to lower cardiovascular mortality (CV …

The current and future status of inotropes in heart failure management

A Arfaras-Melainis, I Ventoulis… - Expert Review of …, 2023 - Taylor & Francis
Introduction Heart failure (HF) is a complex syndrome with a wide range of presentations
and acuity, ranging from outpatient care to inpatient management due to acute …

Artificial intelligence cloud platform improves arrhythmia detection from insertable cardiac monitors to 25 cardiac rhythm patterns through multi-label classification

F Quartieri, M Marina-Breysse… - Journal of …, 2023 - Elsevier
Background Electrocardiogram (ECG) is the gold standard for the diagnosis of cardiac
arrhythmias and other heart diseases. Insertable cardiac monitors (ICMs) have been …

Outcomes with sGC therapy in patients with HFpEF: a meta-analysis of prior trials

RA Thakker, A Elbadawi, A Albaeni, C Perez… - Current Problems in …, 2022 - Elsevier
Soluble guanylate cyclase (sGC) agents have been shown to have possible beneficial
effects in heart failure treatment. Unfortunately, the role of sGC in HFpEF has not been …

[HTML][HTML] Diabetes and risk of heart failure in people with and without cardiovascular disease: systematic review and meta-analysis

K Panchal, C Lawson, C Chandramouli, C Lam… - Diabetes Research and …, 2023 - Elsevier
Background People with diabetes have an increased risk of heart failure (HF), compared to
those without diabetes. However, no comprehensive systematic review and meta-analysis …

Evolution of economic burden of heart failure by ejection fraction in newly diagnosed patients in Spain

C Escobar, B Palacios, V Gonzalez, M Gutiérrez… - BMC Health Services …, 2023 - Springer
Objective To describe healthcare resource utilization (HCRU) and costs, in patients with
newly diagnosed heart failure (HF) according to ejection fraction (EF) in Spain. Methods …